http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2134413-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1ca2fe5a1e9022aa0323cbb48d30f5e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 |
| filingDate | 1994-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b8532c3ad476378165fc1b3fc050076 |
| publicationDate | 1995-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2134413-A1 |
| titleOfInvention | Use of Hydroxychloroquine for Treatment of Graft-Versus-Host Disease |
| abstract | Disclosed is a pharmaceutical composition for treating graft-versus-host disease comprising an effective amount of hydroxychloroquine in admixture with a pharmaceutically acceptable carrier or diluent. Also disclosed is a pharmaceutical composition for suppressing alloreactivity arising from reactions of donor T lymphocytes against recipient cells comprising an amount of hydroxychloroquine effective to suppress such alloreactivity, in admixture with a pharmaceutically acceptable carrier or diluent. |
| priorityDate | 1993-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491057 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3652 |
Total number of triples: 18.